26 August 2016
Coloplast – transactions in connection with share buy-back programme
As mentioned in Announcement No. 4/2016 Coloplast has initiated the first part of the share buy-back programme totalling up to DKK 1bn. The first part of the programme of DKK500m is expected to take place from 29 February, 2016 to 29 August, 2016.
The following transactions have been executed during the period 22 August – 25 August 2016:
|Date||Number of shares||Buying price||Amount DKK|
|22 August 2016||1,000||506.00||506,000.00|
|23 August 2016||1,000||505.00||505,000.00|
|24 August 2016||5,000||503.50||2,517,500.00|
|25 August 2016||8,403||502.00||4,218,306.00|
|Accumulated until now under the programme||
Henceforth, Coloplast owns 4,450,854 treasury B shares of DKK 1 equal to 2.06% of the company’s total share capital.
The first part of Coloplast’s share buy-back programme initiated 29 February 2016 (see announcement No. 4/2016) is hereby finalized.
Tel. +45 4911 1800
For further information, please contact
Investors and analysts
Head of Investor Relations
Tel. +45 4911 1800/+45 4911 3376
Press and the media
Sr. Media Relations Manager
Tel. 4911 3095
This announcement is available in a Danish and an English language version. In the event of discrepancies, the Danish version shall prevail.
Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate healthcare.
Our business includes ostomy care, urology and continence care and wound and skin care. We operate globally and employ more than 10,000 people.
The Coloplast logo is a registered trademark of Coloplast A/S. © 2016-08 All rights reserved Coloplast A/S, 3050 Humlebæk, Denmark.GlobeNewswire
Last updated on: 27/08/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.